Amphastar Pharmaceuticals - Stock Price History | AMPH

Historical daily share price chart and data for Amphastar Pharmaceuticals since 2020 adjusted for splits. The latest closing stock price for Amphastar Pharmaceuticals as of January 17, 2020 is 20.08.
  • The all-time high Amphastar Pharmaceuticals stock closing price was 25.28 on March 01, 2019.
  • The Amphastar Pharmaceuticals 52-week high stock price is 25.43, which is 26.6% above the current share price.
  • The Amphastar Pharmaceuticals 52-week low stock price is 16.71, which is 16.8% below the current share price.
  • The average Amphastar Pharmaceuticals stock price for the last 52 weeks is 20.71.
Amphastar Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 20.8106 19.7600 25.2800 17.0700 19.2900 -3.07%
2018 18.4456 19.1700 22.5100 14.6300 19.9000 3.43%
2017 16.6801 18.5000 19.7500 12.2000 19.2400 4.45%
2016 15.9103 13.7000 21.5500 10.5300 18.4200 29.44%
2015 14.2957 11.8400 18.1900 10.7800 14.2300 22.57%
2014 10.6285 8.7500 12.3900 8.6900 11.6100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.943B $0.295B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $63.630B 11.60
Teva Pharmaceutical Industries (TEVA) Israel $11.598B 4.72
Mylan (MYL) United States $11.339B 5.09
Bausch Health Cos (BHC) Canada $10.485B 6.92
Dr Reddy's Laboratories (RDY) India $6.838B 17.94
ASPEN PHARMACR (APNHY) South Africa $3.743B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.286B 12.45
Homology Medicines (FIXX) United States $0.775B 0.00
Voyager Therapeutics (VYGR) United States $0.543B 0.00
Assembly Biosciences (ASMB) United States $0.462B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.441B 0.60
Progenics Pharmaceuticals (PGNX) United States $0.407B 0.00
Sol-Gel Technologies (SLGL) Israel $0.267B 0.00
Akorn (AKRX) United States $0.178B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.164B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.140B 0.00
CymaBay Therapeutics (CBAY) United States $0.135B 0.00
Teligent (TLGT) United States $0.022B 0.00
China Pharma Holdings (CPHI) China $0.013B 0.00